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Background: Post-transcriptional 3′ end processing is a key component of RNA regulation. The abundant and
essential RNA subunit of RNase MRP has been proposed to function in three distinct cellular compartments and
therefore may utilize this mode of regulation. Here we employ 3′ RACE coupled with high-throughput sequencing
to characterize the 3′ terminal sequences of human MRP RNA and other noncoding RNAs that form RNP
complexes.
Results: The 3′ terminal sequence of MRP RNA from HEK293T cells has a distinctive distribution of genomically
encoded termini (including an assortment of U residues) with a portion of these selectively tagged by oligo(A) tails.
This profile contrasts with the relatively homogenous 3′ terminus of an in vitro transcribed MRP RNA control and
the differing 3′ terminal profiles of U3 snoRNA, RNase P RNA, and telomerase RNA (hTR).
Conclusions: 3′ RACE coupled with deep sequencing provides a valuable framework for the functional
characterization of 3′ terminal sequences of noncoding RNAs.
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The addition of non-templated nucleotides to the 3′ ends
of RNA molecules is a widespread mechanism for their
regulation. Beyond the familiar long poly(A) tails of
messenger RNAs, short 3′ tailing of uridine [1-4] and
adenosine [5-7] nucleotides to noncoding RNAs is gathe-
ring increasing appreciation. These simple oligonucleotide
additions (one to ~20 identical bases) can alter the stabi-
lity, binding partners or activity of the enzymatic reactions
in which these RNAs participate. Further, many of these
3′ terminally extended noncoding RNAs, including U6
spliceosomal RNA [8], tRNAs [4] and several snoRNAs
[9,10], have annotated termini flanked by a stretch of
genomically encoded U’s. The detailed interplay of tran-
scriptional termination, trimming and post-transcriptional
oligonucleotide addition has been elegantly characterized
for a few systems [11], but the precise 3′ processing* Correspondence: thomas.cech@colorado.edu
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distribution, and reproduction in any mediumcascade and functional termini for many other critical
noncoding RNAs remain unclear.
RNase MRP is a ribonucleoprotein complex with a
single RNA component (MRP RNA) transcribed by RNA
polymerase III [12]. Mutation of the sole MRP RNA
genomic locus results in inviable yeast [13] and a spec-
trum of pleiotropic human diseases [14], supporting the
assertion that MRP RNA is essential to eukaryotic life. In
association with at least 10 proteins in humans [15,16],
MRP RNA is implicated in the specific endoribonu-
cleolytic cleavage [17,18] of several vital RNA substrates
[19-24] found in the nucleolus [25,26], cytoplasm [24,27]
and possibly mitochondria [28,29] of the eukaryotic cell.
All of the MRP proteins also associate with the RNase
P RNA [15,30] to form the enzyme responsible for the
cleavage of tRNA 5′ leader sequences. Thus, RNase MRP
requires tight regulation to discern its proper RNA
subunit and cleave its many substrates.
Because 3′ end processing is a prevalent and potent
means of regulation for other noncoding RNAs and
because one instance of dramatic 3′ extension of MRP
RNA was previously reported [31], we sought toentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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human cells. Combining aspects of various protocols
[32-34], we employed a modified 3′ RACE with deep se-
quencing protocol and found a distribution of genomically
encoded 3′ ends including variable U’s beyond the anno-
tated 3′ nucleotide. Modest oligo(A) addition was also
observed, particularly after more than one uridine. This
profile contrasted with distinct distributions of U’s and A’s
on other noncoding RNAs and the relatively homogenous
3′ terminus of an in vitro transcribed control MRP RNA.
Results
To comprehensively define the 3′-hydroxyl ends of en-
dogenous RNA molecules in HEK293T cells, we adapted
an RNA ligase-mediated 3′ RACE strategy coupled to
deep sequencing (Figure 1). While similar methods have
been previously reported [33], our protocol incorporated
a few modifications. Precise 3′ terminal nucleotides were
demarcated by ligation of whole cell RNA preparationsFigure 1 3′ RACE with deep sequencing, schematic of method
used. a Ligation of whole cell RNA with 5′ degenerate indexed
appendices (orange), b Reverse transcription with appendix-specific
primer, c 3′ RACE-PCR selection with indexed (black and white
barcode) gene-specific F primer and universal R primer containing
Illumina adapter sequences (blue), d Library amplification with
general primers to the adapter sequences, e High-throughput insert
and RACE index sequencing on Illumina MiSeq (sequencing primers
in purple), f Bioinformatic trimming of reads to analyze 3′ terminal
sequences (yellow). See Methods for detailed protocol.with four distinct oligoribonucleotide appendices, each
containing a different 5′ terminal base and internal
barcode to minimize structural bias during this reaction
[32,35]. Further, to ensure signal from low abundance
RNA species, a library amplification step was included
after the RACE selection [34].
We obtained an average of 955,000 trimmed reads
(range of 53,997 – 2,235,651 for 6 libraries, see Methods)
per experiment for endogenous MRP RNA. Unlike typical
pipelines, alignment of sequences to the reference genome
was not performed, since this would have eliminated
detection of extensions not mapping to the genomic tem-
plate. Instead, raw sequencing reads were filtered to obtain
a rigorous set where each read contained both a 3′ region
of MRP RNA (Additional file 1: Table S1) and one of the
appendix oligonucleotides. Since our focus was 3′ exten-
sion, reads displaying RNA termini truncated upstream of
the annotated 3′ end were excluded by this analysis.
Endogenous MRP RNA molecules displayed a distinc-
tive profile of 3′ ends. While the majority of these termini
mapped to the RMRP gene locus (Figure 2a, upper panel),
we observed a clear preference in this cell type for one
previously annotated end (…CUGU, ~62%) over another
(…CU, ~1%). Additional uridines beyond these ends were
also detected; these may arise from primary transcrip-
tional termination beyond the annotated end, or post-
transcriptional oligouridylation by 3′ uridyltransferases
[36]. While these possible mechanisms cannot be dis-
tinguished by our methods, the apparent greater propen-
sity for four or five uridines presumably indicates these
endings are more frequently generated or are more stable
species in this cell type. Among the ~9% fraction of
3′ ends that failed complete alignment to the genomic
template, most were additions of adenosines to geno-
mically encoded termini. Interestingly, these A’s were most
likely to appear after multiple U’s (Figure 2b, upper panel),
suggesting different 3′ ends have distinct propensities for
the addition of oligo(A) tails. Our observation that various
lengths of oligo(U) are often followed by an A, but the A
termini are not followed by U’s, was noted previously for
signal recognition particle RNA, 7SK RNA, 5S rRNA and
U6 snRNA [5]. To test whether the observed MRP RNA
3′ ends were specific to the cell line tested, we sequenced
MRP RNA from a second human cell line (K562) and
found it to display similar genomically encoded and
oligo(A) termini (Additional file 2: Figure S1).
To control for the possibility that our library pre-
paration method could contribute to this profile of 3′
ends, we constructed a barcoded in vitro transcript of
MRP RNA (ivt-MRP), spiked it into our cellular RNA,
and prepared a single library for deep sequencing. The
template for ivt-MRP was designed to have the com-
monly annotated …CU 3′ end produced by run-off tran-
scription. As expected for this template, and in contrast
ba
Figure 2 RACE sequencing reveals a distribution of 3′ termini for MRP RNA. a The majority of HEK293T cellular MRP RNA 3′ ends are
genomically encoded (black pie slice), with a modest portion of these containing oligo(A)n additions to these genomically encoded ends
(range of n=1-10, light blue slice). In contrast, while nearly three quarters of the reads from in vitro transcribed MRP (ivt-MRP) are the exact target
sequence (grey slice), the remaining reads consist of single nucleotide additions to this designed end (+A in blue; +C in green; +G in yellow;
+U in red). Both cellular and ivt-MRP displayed a small portion of other simple sequences shown as white slices (i.e. …CUCC, …CUGC, and see
Figure 3). Total trimmed reads = 1,497,440 (cellular) and 906,145 (ivt). b Reads from endogenous MRP terminate at specific nucleotides in the
flanking RMRP gene with non-random abundances (black bars) and distinct probabilities of oligo(A) addition (light blue caps). As an example,
the relative frequency of different numbers (n) of A’s found on one of the genomically encoded termini is illustrated in the inset. The major
genomically encoded end is not observed on ivt-MRP (lower panel), nor is there appreciable propensity for oligo(A) addition. Although a single A
is sometimes added to the designed terminus, C and G are added with similar frequency.
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preciable abundance of the …CUGU ending nor a pen-
chant for additional U’s or A’s (Figure 2b). Rather, 95%
of the ivt-MRP ends represented the designed terminus
(…CU, ~75%) or single nucleotide additions to this
terminus in which each base had a comparable pro-
pensity for incorporation (Figure 2a, lower panel). The
number of reads for indexed ivt-MRP relative to en-
dogenous MRP in the control libraries closely matched
the expected ratio, based on northern hybridization
(Additional file 3: Figure S2). Thus, the relative number
of sequencing reads appears to correlate with relative
RNA abundance in the library. Combined with the ab-
sence of multiple U’s or oligo(A) additions on ivt-MRP,this argues that the presence of these endings on the en-
dogenous RNA directly reflects the MRP termini in vivo.
About 1% of ivt-MRP endings were strikingly complex
(Figure 3a). These extensions beyond the designed 3′
end were complementary to nearby regions of the MRP
RNA sequence (Figure 3b). An attractive mechanism for
generation of these observed termini is 3′ end loopback
or duplex RNA-dependent RNA polymerase extension
by T7 RNA polymerase [37] analogous to that observed
for mouse B2 RNA by RNA polymerase II [38]. The
three examples shown demonstrate distinct registers of
3′ end loopback that would explain the observed exten-
sion sequences. Because such complex termini were
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Figure 3 Loopback extensions on the ivt-MRP 3′ end are observed at low abundance by deep sequencing. a Approximately one per cent
of observed 3′ ends contain complex sequences that are not explained by the in vitro template (violet slice). The majority of the reads from
in vitro transcribed MRP (ivt-MRP) are the exact target sequence (grey slice), while the remainder can be categorized as single nucleotide
additions to this designed end (+A in blue; +C in green; +G in yellow; +U in red), or other simple sequences (i.e. …CUCC, …CUGC, white slice).
b Examples of possible duplex registers to template the observed sequences of loopback extensions.
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complex 3′ termini were likely to have been produced
during T7 transcription and then faithfully retained
through library preparation and sequencing.
One key advantage to this 3′ RACE sequencing
method is the transcriptome-wide scope of the ligated
cDNA library. Thus, with this library in hand, any RNA
of interest can be amplified and subjected to deep 3′ ter-
minal profiling (Figure 4). We found that RNase P RNA,
which is structurally similar to MRP RNA and also
transcribed by RNA polymerase III, had a distribution of
additional genomically encoded U’s beyond its annotated
3′ end and virtually no propensity for oligo(A) addition.
U3 snoRNA, transcribed by RNA polymerase II [11],
was comparatively homogeneous with 99.5% of reads
yielding the annotated 3′ terminus. In contrast, the RNA
component of human telomerase, also transcribed by
RNA polymerase II [39], had a greater propensity for
oligo(A) addition, with each genomically encoded ter-
minus being more likely to have multiple A’s than none(n = 5 A’s, average mode for endings shown) (Figure 4b,
lowest panel).
To assess whether similar 3′ termini are captured in
other published datasets, we used our bioinformatic
pipeline to reanalyze raw poly(A)-depleted RNA sequen-
cing data [4,40,41] and compared our profiles with
theirs. Of course, the read depth for any particular RNA
was much lower in the published whole-transcriptome
datasets, e.g. an average of 1000 reads for MRP RNA per
dataset compared with the average of 955,000 obtained
here. On the noncoding RNAs analyzed for this study,
we found a similar range of genomically encoded se-
quences with templated and non-templated oligo(U) and
oligo(A) additions (Additional file 4: Table S2). Complex
3′ ends were also observed at very low abundance,
though with properties distinct from those presented in
Figure 3. Such endings included attachment of micro-
RNAs, ribosomal RNA fragments and short sense or
longer antisense regions of the RNA being analyzed
(Additional file 5: Figure S3) and were idiosyncratic to
a b
Figure 4 Other noncoding RNAs display 3′ end profiles somewhat different from those of endogenous MRP RNA. a Categorized reads
and b genomically encoded/oligo(A) addition profiles are shown for RNase P RNA, U3 snoRNA and the RNA component of human telomerase,
hTR. Genomically encoded termini are in black, oligo(A)n additions to genomically encoded ends are in blue, other sequences in white. The top
sequence listed for each RNA is the annotated 3′ terminus. A representative probability distribution for the number (n) of A’s is included for hTR
in inset. Total trimmed reads = 353,190 (RNase P); 246,485 (U3 snoRNA); and 1,013 (hTR).
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Table S2). Thus, these initially-more-interesting exten-
sions have the hallmarks of artifacts.
Discussion
The information content of the eukaryotic genome is
greatly expanded in the transcriptome through post-
transcriptional processing events. Well-studied examples
include alternative splicing, RNA editing, and modi-
fications including methylation and pseudouridylation.
Recently, Li et al. characterized extensive differencesbetween RNA and DNA sequences within protein cod-
ing genes that produce corresponding peptides with se-
quences that deviate from the genomic template [42].
The RNA 3′ end is another site at which post-trans-
criptional modification occurs and increases the infor-
mation content of the transcriptome. Here, we analyze
MRP RNA and other human noncoding RNAs at a
much greater sequencing depth than usual, and find a
limited repertoire of sequence additions.
High-throughput sequencing is a powerful technology
with continually emerging and illuminating applications.
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technique has provided unprecedented insights into low
abundance functional 3′ termini heretofore underappre-
ciated [33]. General appendix-tagged cDNA libraries such
as the ones produced in this study contain whole trans-
criptome information that can be specialized (Figure 1c)
to amplify any RNA of interest. Even RNAs with non-
ligatable 3′ modifications, such as the 2′,3′-cyclic
phosphate on U6 snRNA [43], could be analyzed by
comparison of libraries with and without enzymatic
3′-end deprotection (i.e. HCl followed by shrimp alkaline
phosphatase treatment [44]). A further asset of the RACE
sequencing technique is the ability to multiplex this
general protocol at several stages, as demonstrated by
orthogonal barcoding on the appendices, the control
ivt-MRP RNA and the gene-specific RACE primer. Thus,
comparison of 3′ terminal profiles across fractionated cel-
lular compartments, associated protein partners, time
courses or stress conditions enables the regulation of
3′ terminal extension to be comprehensively defined.
Our 3′ RACE sequencing analysis of the steady-state
populations of four noncoding RNAs indicates that each
RNA has a distinct repertoire of 3′ termini. Like MRP
RNA, RNase P RNA is transcribed by RNA polymerase
III and also has additional uridines beyond the annotated
3′ end. However, oligoadenylation is much less pro-
minent with RNase P than with MRP RNA. Turning to
the RNA polymerase II transcripts, we find U3 snoRNA
to have a very homogeneous end. While processing in-
termediates with additional U’s have been observed in
reporter expression systems of U3 snoRNA [45], en-
dogenous U3 is often present as a single species [46]
consistent with its highly efficient processing. Although
previous examination [47] of hTR 3′ sequences found
the primary terminus to be unadenylated as we did, our
data clearly show that a subpopulation of hTR termini
have oligo(A) additions. This population was missed by
the limited number of clones sequenced in the earlier
study and emphasizes the value of deep sequencing.
The oligo(A) additions found in this study are consis-
tent with those added by the TRAMP complex to nu-
clear RNAs targeted by the RNA exosome (for review
see [48]). Along with its primary function in RNA sur-
veillance and decay of both nuclear and mRNAs [49],
the exosome processes the 3′ termini of some non-
coding RNAs (for example [50]). It is plausible that the
transcript-specific variations in oligo(A) propensity we
observe are correlated with the fraction of each RNA or
specific terminus that is bound for exosomal processing
or destruction. In that case, the relatively oligo(A)-less
U3 snoRNA and RNase P RNA may be at one end of
the stability spectrum relative to the highly oligo-
adenylated hTR (Figure 4). Alternatively, maturation of
other snoRNAs has been demonstrated to involveoligoadenylation by noncanonical poly(A) polymerase
PAPD5 and trimming by the poly(A) specific ribonucle-
ase PARN [51]. The distribution of oligoadenylations
observed on the RNAs in this study may represent inter-
mediates of a similar maturation process.
Much of the initial incentive for this work came from
the finding of 3′ extensions on MRP RNA by Maida et al.
[31], who reported full-length antisense extensions. Al-
though no such extensions were found by our method,
long double-stranded RNA might be resistant to amplifi-
cation and sequencing, so the absence of such sequences
in our study cannot be taken as proof that they don’t exist.
We had observed MRP RNA to have complex 3′ endings
with potential loopback character akin to those in Figure 3
at low and variable frequency in some early total RNA
preparations. Because the abundance of complex exten-
sions on endogenous MRP peaked at 1% of trimmed
reads, hypothetical contamination of non-indexed ivt-
MRP (with complex extension abundance of 1%) could
not account for all of these sequences. While it is temp-
ting to speculate that the small level of loopback exten-
sions on some preparations of endogenous MRP RNA
could be explained by an unidentified variation in cellular
growth conditions, we have no further data to support this
model.
Conclusion
While evidence for 3′ heterogeneity on MRP RNA was
presented as many as 30 years ago [52,53], to our know-
ledge quantitative profiling has not been previously
reported. As an essential RNA demanding tight regula-
tion for cleaving its diversely localized substrates, 3′ ter-
minal extension likely plays a role in MRP RNA control.
The distinctive profile of U’s and A’s on MRP RNA
described here provides the necessary framework for
testing this hypothesis, prompting further study into the
potentially distinct 3′ terminal profiles of RNase MRP
subpopulations in the nucleolus and cytoplasm, or asso-
ciated with different subcomplexes of MRP proteins.
The potent ability of 3’ RACE sequencing to isolate the
terminal sequences of the MRP RNA from the intricate
mixture of RNAs present in eukaryotic cells makes it an
attractive method to address the functional conse-
quences of these 3′ termini.
Methods
In vitro transcription of barcoded MRP RNAs
MRP RNA (265 nt) was amplified from human genomic
DNA using forward primer mrpF1 (Additional file 6:
Table S3) containing an EcoRI restriction site followed
by T7 promoter and reverse primer mrpR1 containing
restriction sites for SapI and BamHI. Agarose gel puri-
fied (Qiagen) PCR products were co-digested with EcoRI
and BamHI (NEB), re-gel purified and cloned into pUC19
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instructions. Insert sequences were confirmed by direct
sequencing. Index-containing template for in vitro trans-
cription was produced by PCR in 100 μL reactions using
300 ng of MRP plasmid, 1X GC buffer, 400 nM primers
(mrpF1, mrp_index1_R2), 2 mM dNTPs, and 5U
Phusion polymerase in the following program: 98C for
2 min, 30 cycles of 98C for 30 s, 55C for 30 s, 72C for
1 min, and final extension at 72C for 10 min. Template
PCR products were then purified on agarose gels
(Qiagen) and the entire eluate was used as template for
in vitro transcription in 500 μL reactions containing
20 mM MgCl2, 5 mM NTPs, 10 mM DTT, 4 mg/mL
yeast pyrophosphatase (Sigma) and T7 RNA polymerase.
In vitro transcription proceeded for 30 min at 37C and
was stopped by phenol extraction with ethanol precipita-
tion. Precipitated RNA was treated with 50U RQ1
DNase (Promega) and stopped by phenol extraction with
ethanol precipitation according to the manufacturer’s
instructions. DNase-treated RNA was then PAGE
purified and stored in water at -80C.
Cellular RNA preparation
HEK293T cells were cultured in DMEM augmented with
10% FBS and pen/strep. 90% confluent cells were har-
vested with trypsin, washed twice with PBS and flash
frozen in liquid nitrogen in aliquots of approximately
50 million cells. Cell pellets were extracted for whole cell
RNA with Trizol reagent (Ambion) according to the
manufacturer’s instructions, and quantified for total
RNA by absorbance at 260 nm (via Nanodrop) and MRP
RNA by northern blot comparison with ivt-MRP. 50 μg
whole cell RNA containing approximately 15 ng en-
dogenous MRP with or without 15 ng ivt-MRP was
subjected to 50U of RQ1 DNase (Promega) and phenol
extracted with ethanol precipitation according to the
manufacturer’s protocol. Four 5 μg aliquots of each
sample were then depleted of ribosomal RNA using the
RiboZero rRNA Removal Kit (Epicentre), and 800 ng
rRNA-depleted sample were subsequently treated with
2U alkaline phosphatase (Roche) and phenol extracted
with ethanol precipitation as per the manufacterer’s
instructions.
Ligase mediated 3′ RACE with deep sequencing
Library preparation was performed with a protocol
similar to methods previously reported [33] with modifi-
cations. Pre-ligation reactions (23 μL) contained 10%
PEG8000, 125 ng of RQ1, RiboZero, AP-treated whole
cell RNA prepared as above and 40 pmol of one RNA
appendix from the four listed in Additional file 7:
Table S4, so that four separate reactions were carried
out for each RNA sample. Pre-ligation reactions were
heated to 85C for 5 min and immediately transferred to37C. 10U of T4 RNA Ligase 1 were added to the melted
RNAs along with final concentrations of 1X T4 RNA
Ligase Reaction Buffer and 1 mM ATP. Ligation reactions
(30 μL) were incubated at 37C for 30 min and stopped by
phenol extraction with ethanol precipitation. Half of each
ligation reaction was annealed with 10 pmol RT_primer
and 25 nmol dNTPs for 5 min at 65C (35 μL reaction
volume) and immediately transferred to 55C for reverse
transcription in 50 μL reactions performed with 35 mM
Tris, 52.5 mM KCl, 5 mM MgCl2, 10 mM DTT and
200 U of Superscript III (Invitrogen). Reverse transcription
lasted 50 min followed by heat inactivation at 85C for 5
min. 5 μL RT reaction was used as template for RACE
and addition of Illumina adapters with 1X GC Buffer,
2 mM MgCl2, 10% DMSO, 400 nM primers X_RACEF/
3’universal_R1, 400 μM dNTPs and 1.25U Phusion poly-
merase in 25 μL final volume with the following program:
98C for 2 min, 18 cycles of 98C for 30 s, 65C for 30 s, 72C
for 1 min, and final extension at 72C for 10 min. The en-
tire RACE reaction was loaded on 2.5% agarose gels and
amplicons of ~150-600 bp were excised for purification
(Qiagen). Purified RACE products (30 μL) were used as
template for library amplification in 100 μL reactions
containing 1X HF Buffer, 2 mM MgCl2, 400 nM primers
Gen_primer-F2/Gen_primer-R2, 400 μM dNTPs and 5U
Phusion polymerase with the following program: 98C for
2 min, 14 cycles of 98C for 30 s, 58C for 30 s, 72C for 1
min, and final extension at 72C for 10 min. These nested
amplicons were subjected to PCR cleanup (Qiagen), quan-
tified by Qubit and Bioanalyzer, diluted to 2 nM in
10 mM Tris-HCl, pH8.5, and combined for sequencing.
3–3.2 pM pooled libraries containing 30% phiX control
V3 (Illumina) were run on the Illumina MiSeq following
the manufacturer’s instructions.
Data analysis
300 basepair reads were assessed for quality using FASTX
software and trimmed from adapters to isolate relevant
insert content (Figure 1f) using a custom python script.
Briefly, reads containing both a perfect appendix sequence
and perfect search primer (Additional file 1: Table S1) for
the RNA of interest were selected for processing, and this
set was further trimmed to yield reads containing the
5′end of the search primer through the 5′ end of the
appendix (indicated region in Figure 1f). Identical
trimmed reads were then collapsed to assess the abun-
dance of each terminus and the depth of variation in
3′ terminal sequences.Additional files
Additional file 1: Table S1. Search primers for bioinformatics
assessment of 3′ ends.
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cells.
Additional file 3: Figure S2. Northern analysis of ivt-MRP and total
RNA from HEK293T cells.
Additional file 4: Table S2. Summary of 3′ termini from publicly
available datasets [4,40,41].
Additional file 5: Figure S3. Examples of complex “extensions” found
in publically available datasets.
Additional file 6: Table S3. Primers used in this study.
Additional file 7: Table S4. Appendix RNA oligonucleotide sequences.
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